Journal of Biological Chemistry · 1990 · 116 citations · 41 references
Life SciencesBiochemistryMolecular BiologyCellular MetabolismMetabolismOncogenesLipid MetabolismPhospholipid MetabolismRas Family OncogenesSphingolipid MetabolismCdp-diacylglycerol PathwayCholine MetabolismPhosphatidylcholine MetabolismPhosphatidylinositol MetabolismTurnover Rate Analysis
The effect of expression of the Harvey-ras oncogene on phosphatidylcholine metabolism in C3H10T1/2 mouse fibroblast cells was examined. There were multiple changes in the CDP-choline pathway for phosphatidylcholine biosynthesis in the ras-expressing cells. The activity of the first enzyme in the pathway, choline kinase, was stimulated 1.9-fold, while the activity of the second enzyme, CTP:phosphocholine cytidylyltransferase, was decreased by one-half. High levels of intracellular phosphocholine measured in the ras cells were consistent with the altered activities of choline kinase and cytidylyltransferase. The overall rate of phosphatidylcholine synthesis appeared to be increased because the turnover rate of phosphocholine from the intracellular pool was higher in the ras-transfected cells. There also appeared to be an increased rate of phosphatidylcholine degradation in ras-expressing C3H10T1/2 cells. Very high levels of glycerophosphocholine (6-fold increased over control cells) suggested that phospholipase A was activated in these cells. These results indicate that the ras oncogene product directly or indirectly causes an increased turnover of phosphatidylcholine in C3H10T1/2 cells.
41
A pharmacokinetic analysis program (multi) for microcomputer.
Kiyoshi Yamaoka, Yusuke Tanigawara, Terumichi Nakagawa et al. · Journal of Pharmacobio-Dynamics · 1981 · 2.5K citations · Full text
J Preiss, Carson R. Loomis, W. Robert Bishop et al. · Journal of Biological Chemistry · 1986 · 987 citations · Full text